Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2025)

Contineum Therapeutics has reported Return on Capital Employed over the past 2 years, most recently at 0.38% for Q3 2025.

  • Quarterly results put Return on Capital Employed at 0.38% for Q3 2025, down 17.0% from a year ago — trailing twelve months through Sep 2025 was 0.38% (down 17.0% YoY), and the annual figure for FY2024 was 0.31%, changed.
  • Return on Capital Employed for Q3 2025 was 0.38% at Contineum Therapeutics, down from 0.36% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CTNM hit a ceiling of 0.09% in Q1 2024 and a floor of 0.38% in Q3 2025.